No Detail Found!

Interaction Between MTHFR Polymorphisms and Maternal Age Increases the Risk of Congenital Heart Deffects in Down Syndrome.

Author(s)
SJustin Carlus Cardiogenetic Unit, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Kingdom of, Saudi Arabia
AtiyehM Abdallah Cardiogenetic Unit, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Kingdom of, Saudi Arabia; West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's Hospital, Birmingham, United Kingdom
Abdulhadi H AlMazroea Cardiogenetic Unit, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Kingdom of, Saudi Arabia
Mazen Khalid AlHarbi Al-Rayan Colleges, Al-Madinah Kingdom of, Saudi Arabia
KhalidM AlHarbi Cardiogenetic Unit, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Kingdom of, Saudi Arabia
Abstract
Congenital heart disease (CHD) is responsible for one-third of all congenital anomalies in newborns and is the most frequent cause of infant deaths. Several cohort studies show that down syndrome (DS) and CHD are associated, and maternal hyperhomocysteinemia is an independent risk factor for CHD. In Saudi Arabia CHD represents one of the most important health problems. Here we examined the association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and CHD and DS coinheritance in patients from Al Madinah, Saudi Arabia. MTHFR rs1801133 and rs1801131 polymorphisms were genotyped in 99 CHD patients with or without DS and 126 ethnically matched controls by allelic discrimination. Of 99 patients with CHD, 26 had DS. MTHFR rs1801133 and rs1801131genotypes and alleles were not significantly different between controls and CHD patients. Further, in CHD individuals, these genotypes failed to show any significant association with DS. However, maternal age increased the risk of CHD in DS (OR=5.32; 95% CIs 1.43-19.82; p=0.013). Mantel-Haenszel analysis showed that MTHFR polymorphisms confounded the effect of maternal age CHD in DS. MTHFR polymorphisms appear to be risk factors for CHD in DS.
Publication Details
Page(s) 865-870
Published Journal: Pakistan Journal of Zoology, Volume: 51, Issue: 3, Year: 2019

Request the full text from PASTIC

Keywords
Down Syndrome, Polymorphism, Saudi Arabia., Methylenetetrahydrofolate reductase, Congenital heart disease, Maternal age
References
Abhinand , P.A.,Shaikh , F.,Bhakat , S.,Radadiya , A.,Bhaskar , L.V.,Shah , A.,Ragunath , P.K., 2016.Insights on the structural perturbations in human MTHFR Ala222Val mutant by protein modeling and molecular dynamics,J. Biomol. Struct. Dynam. 34 1057866 -905
Asim , A.,Agarwal , S.,Panigrahi , I.,Saiyed , N.,Bakshi , S., 2017.MTHFR promoter hypermethylation may lead to congenital heart defects in down syndrome,Intractable Rare Dis. Res. 6 295 -298
Bhaskar , L.V.,Murthy , J.,VenkateshBabu,G., 2011.Polymorphisms in genes involved in folate metabolism and orofacial clefts,Arch. Oral Biol 01 723 -737
Blom , H.J.,Smulders , Y., 2011.Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects,J. Inherit. Metab. Dis. 34 75 -81
Bozovic , I.B.,Vranekovic , J.,Cizmarevic , N.S.,Mahulja-Stamenkovic , V.,Prpic , I.,BrajenovicMilic , B., 2010.MTHFR C677T and A1298C polymorphisms as a risk factor for congenital heart defects in down syndrome,Pediat. Int. Off. J. Japan Pediat. Soc. 03310 1442 -200X
Brandalize , A.P.,Bandinelli , E., dos Santos, P.A.,Roisenberg , I.,Schuler-Faccini , L., 149A.Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for down syndrome and congenital heart defects,Am. J. med. Genet 32989 2080 -2087
Brandalize , A.P.,Bandinelli , E., dos Santos, P.A.,Schuler-Faccini , L., 2010.Maternal gene polymorphisms involved in folate metabolism as risk factors for down syndrome offspring in Southern Brazil, 29 95 -101
Czeizel , A.E.,Vereczkey , A.,Szabo , I., 2015.Folic acid in pregnant women associated with reduced prevalence of severe congenital heart defects in their children: A national population-based casecontrol study,Eur. J. Obstet. Gynecol.Reprod. Biol 06 34 -39
de Rubens-Figueroa , J.,del Pozzo-Magana , B.,PablosHach , J.L.,Calderon-Jimenez , C.,CastrejonUrbina, 2003.Heart malformations in children with Down syndrome,Rev. Esp. Cardiol. 56 894 -899
Dolk , H.,Loane , M.,Garne , E., 2011.Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005, 123 841 -849
Ellesøe , S.G.,Workman , C.T.,Bouvagnet , P.,Loffredo , C.A.,McBride , K.L.,Hinton,van Engelen , K.,Gertsen , E.C.,Mulder , B.J.M.,Postma , A.V.,Anderson , R.H.,Hjortdal , V.E.,Brunak , S.,Larsen , L.A., 2018.Familial co-occurrence of congenital heart defects follows distinct patterns,Eur. Heart J. 39 1015 -1022
Elsayed , G.M.,Elsayed , S.M.,Ezz-Elarab , S.S., 2013.Maternal MTHFR C677T genotype and septal defects in offspring with Down syndrome: A pilot study,Egyptian J. med. Hum. Genet 09 39 -44
Fenech , M., 2011.Micronuclei and their association with sperm abnormalities, infertility, pregnancy loss, pre-eclampsia and intra-uterine growth restriction in humans,Mutagenesis 26 63 -67
Feng , Y.,Wang , S.,Chen , R.,Tong , X.,Wu , Z.,Mo , X., 2015.Maternal folic acid supplementation and the risk of congenital heart defects in offspring: A meta-analysis of epidemiological observational studies,Scient. Rep 5 8506 -
Ferencz , C.,Neill , C.A.,Boughman , J.A.,Rubin , J.D.,Brenner , J.I.,Perry , L.W., 1989.Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic study,J. Pediatr. 3476 80605 -5
Gladki , M.M.,Skladzien , T.,Skalski , J.H., 2015.The impact of environmental factors on the occurrence of congenital heart disease in the form of hypoplastic left heart syndrome,Kardiochir Torakochirur 12 204 -207
Gorini , F.,Chiappa , E.,Gargani , L.,Picano , E., 2014.Potential effects of environmental chemical contamination in congenital heart disease,Pediatr. Cardiol. 35 559 -568
Goyette , P.,Sumner , J.S.,Milos , R.,Duncan , A.M.,Rosenblatt , D.S.,Matthews , R.G.,Rozen , R., 1994.Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification,Nat. Genet 7 195 -200
Guo , Q.N.,Wang , H.D.,Tie , L.Z.,Li , T.,Xiao , H.,Long , J.G.,Liao , S.X., 2017.Parental genetic variants, MTHFR 677C>T and MTRR 66A>G, associated differently with fetal congenital heart defect,Biomed. Res. Int. -
Huhta , J.,Linask , K.K., 2013.Environmental origins of congenital heart disease: The heart-placenta connection,Semin. Fetal Neonatal. Med 05 245 -250
James , S.J.,Pogribna , M.,Pogribny , I.P.,Melnyk , S.,Hine , R.J.,Gibson , J.B.,Yi , P.,Tafoya , D.L.,Swenson , D.H.,V.L. and Gaylor,D.W., 1999.Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for down syndrome,Am. J. clin. Nutr 70 495 -501
Kidd , S.A.,Lancaster , P.A.,McCredie , R.M.,Paediat, 1993.The incidence of congenital heart defects in the ifrst year of life, 29 1754 -349
Kuo , C.F.,Lin , Y.S.,Chang , S.H.,Chou , I.J.,Luo , S.F.,See , L.C.,Yu , K.H.,Huang , L.S.,Chu , P.H., 2017.Familial aggregation and heritability of congenital heart defects,Circulation J. 17 232 -238
Leirgul , E.,Gildestad , T.,Nilsen , R.M.,Fomina , T.,Brodwall , K.,Greve , G.,Vollset , S.E.,Holmstrom , H.,Tell , G.S.,Oyen , N., 2015.Periconceptional folic acid supplementation and infant risk of congenital heart defects in Norway 1999-2009, 29 391 -400
Li , X.,Li , S.,Mu , D.,Liu , Z.,Li , Y.,Lin , Y.,Chen , X.,You , F.,Li , N.,Deng , K.,Deng , Y.,Wang , Y.,Zhu , J., 2013.The association between periconceptional folic acid supplementation and congenital heart defects: A case-control study in China,Prevent. Med 02 385 -389
Locke , A.E.,Dooley , K.J.,Tinker , S.W.,Cheong , S.Y.,Feingold , E.,Allen , E.G.,Freeman , S.B.,Torfs , C.P.,Cua , C.L.,Epstein , M.P.,Wu , M.C.,Lin , X.,Capone , G.,Sherman , S.L.,Bean , L.J., 2010.Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with down syndrome,Genet 34 613 -623
Lu , Y.,Wang , H.,Wang , X., 2011.Relationship of hyperhomocysteinemia in pregnant rats and congenital heart defects in the newborn rats,Zhong Nan Da Xue Xue Bao Yi Xue Ban 36 68 -73
Malik , R.A.,Lone , M.R.,Ahmed , A.,Koul , K.A.,Malla , R.R., 2016.Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population,Indian Heart J. 07 17 -19
Parnell , A.S.,Correa , A., 2017.Analyses of trends in prevalence of congenital heart defects and folic acid supplementation,J. Thorac. Dis. 03 495 -500
Rai , V.,Yadav , U.,Kumar , P.,Yadav , S.K.,Mishra , O.P., 2014.Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: A meta-analysis from 34 studies,PLoS One 9 -
Serra-Juhe , C.,Cusco , I.,Homs , A.,Flores , R.,Toran , N.,Perez-Jurado , L.A., 2014.DNA methylation abnormalities in congenital heart disease,Epigenetics 10 167 -177
Stover , P.J.,Field , M.S., 2011.Trafficking of intracellular folates,Adv. Nutr 2 325 -331
Tandon , R.,Edwards , J.E., 1973.Cardiac malformations associated with down's syndrome,Circulation 47 1349 -1355
Verkleij-Hagoort , A.,Bliek , J.,Sayed-Tabatabaei , F.,Ursem , N.,Steegers , E.,Steegers-Theunissen , R., 143A.Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis,Am. J. med. Genet 31684 952 -960
Xu , A.,Cao , X.,Lu , Y.,Li , H.,Zhu , Q.,Chen , X.,Jiang , H.,Li , X., 2016.A meta-analysis of the relationship between maternal folic acid supplementation and the risk of congenital heart defects,Int. Heart J. 57 054 -728
Yang , M.,Gong , T.,Lin , X.,Qi , L.,Guo , Y.,Cao , Z.,Shen , M.,Du , Y., 2013.Maternal gene polymorphisms involved in folate metabolism and the risk of having a down syndrome offspring: A meta-analysis,Mutagenesis 28 661 -671
Yigit , S.,Karakus , N.,Inanir , A., 2013.Association of MTHFR gene C677T mutation with diabetic peripheral neuropathy and diabetic retinopathy,Mol. Vis 19 1626 -1630
Yu , D.,Zhuang , Z.,Wen , Z.,Zang , X.,Mo , X., 2017.MTHFR A1298C polymorphisms reduce the risk of congenital heart defects: A meta-analysis from 16 case-control studies,Italian J. Pediat. 43 108 -
Zhang , R.,Huo , C.,Wang , X.,Dang , B.,Mu , Y.,Wang , Y., 2018.Two common MTHFR gene polymorphisms (C677T and A1298C) and fetal congenital heart disease risk: An Updated metaanalysis with trial sequential analysis,Cell Physiol 45 2483 -2496
0

Citations

0

Downloads

38

Views